Role of Rho in the pathophysiology of bronchial asthma

Rho 在支气管哮喘病理生理学中的作用

基本信息

  • 批准号:
    15590805
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

This study was designed to determine involvement of Rho in the pathophysiology of bronchial asthma such as bronchial hyperreactivity, β-adrenergic desensitization, and airway remodeling. After exposure of the fura-2 loaded strip of tracheal smooth muscle to sphingosine 1-phosphate (S1IP,10 μM) for more than 15 min, contraction by methacholine(MCh), a muscarinic receptor agonist, was markedly augmented in a time-dependent fashion. However, concentration of intracellular Ca^<2+>([Ca^<2+>]i) by MCh was not affected. The increased response to MCh (bronchial hyperreactivity) by S1P was antagonized in the presence of 0.01-1 μM Y-27632, a selective inhibitor of Rho-kinase, in a concentration-dependent fashion. Pre exposure to pertussis toxin over 6 hours also prohibited the increased response to MCh by S1P. Next, after exposure of the tissues to S1P (<1 μM) for an equivalent time, the inhibitory effect of isoproterenol (ISO), a β-adrenergic receptor agonist, against MCh-induced contraction wa … More s markedly attenuated without no change in [Ca^<2+>]i. The reduced responsiveness to ISO (desensitization of β-adrenergic receptors) by S1P was inhibited by Y-27632 in a concentration-dependent fashion. Pre exposure to pertussis toxin over an equivalent time also prohibited the reduced response to ISO by S1P. On the other hand, after repeated exposure to ISO every 30 min, response to ISO was gradually attenuated with an increase in [Ca^<2+>]i. This reduced responsiveness to ISO was inhibited in the presence of verapamil, a selective antagonist of voltage-dependent Ca^<2+> channels. In cultured bronchial smooth muscle cells, S1P phosphorylated myosin phosphatase targeting protein (MYPT1) that is a specific protein in myosin phosphatase affected by Rho-kinase. Proliferation of the bronchial smooth muscle cells (airway remodeling) was reduced by Y-27632 in a concentration-dependent fashion. In conclusion, Rho/Rho-kinase processes play an important role in the pathophysiology of bronchial asthma. Less
这项研究旨在确定RHO参与支气管哮喘的病理生理,例如支气管高反应性,β-肾上腺素脱敏和气道重塑。在将气管平滑肌的Fura-2载液条暴露于1-磷酸盐(S1IP,10μM)中,持续15分钟以上,以时间依赖性的方式显着增强了毒蕈碱受体激动剂的甲氧醇(MCH)(MCH)(MCH)。但是,MCH受到MCH的细胞内Ca^<2+>([Ca^<2+>] i)的浓度没有影响。在0.01-1μmy-27632的存在下,S1P对MCH(支气管高反应性)的反应增加,这是一种浓度依赖性的Rho-kinase的选择性抑制剂。在6小时内暴露于百日咳毒素之前,也禁止S1P对MCH的反应增加。接下来,将时间曝光在同等时间内暴露于S1P(<1μm)之后,异丙肾上腺素(ISO)的抑制作用,一种β-肾上腺素能受体激动剂,对MCH诱导的收缩wa…在[Ca^<2+>] i的情况下更明显地减弱而没有变化。 Y-27632以浓度依赖性的方式抑制了S1P对ISO(β-肾上腺素能受体脱敏)的反应性降低。在同等时间内暴露于百日咳毒素的情况下,S1P也禁止对ISO的响应减少。另一方面,在每30分钟反复接触ISO后,对ISO的反应逐渐减弱,[Ca^<2+>] i。在维拉帕米(Verapamil)存在的情况下,对ISO的反应性降低是电压依赖性Ca^<2+>通道的选择性拮抗剂的存在。在培养的支气管平滑肌细胞中,S1P磷酸化的肌球蛋白磷酸酶靶向蛋白(MYPT1)是受Rho-激酶影响的肌球蛋白磷酸酶中的特定蛋白。 Y-27632以浓度依赖性方式减少了支气管平滑肌细胞(气道重塑)的增殖。总之,Rho/Rho-激酶过程在支气管哮喘的病理生理学中起重要作用。较少的

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Clinical use of β_2-adrenergic receptor agonists besed on their intrinsin efficacy
基于内联功效的β_2-肾上腺素受体激动剂的临床应用
Clinical use of β_2-adrenergic receptor agonists besed on their intrinsic efficacy.
β_2-肾上腺素能受体激动剂的临床使用取决于其内在功效。
Involvement of Ca^<2+> mobilization in tachyphylaxis to β-adrenergic receptors in trachalis.
Ca 2+ 动员参与气管中β-肾上腺素能受体的快速耐受。
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kume H;Ishkawa T;Oguma T;Ito S;Shimokata K;Kotlikoff MI
  • 通讯作者:
    Kotlikoff MI
Clinical use of β_2-adrenergic receptor agonists based on their intrinsic efficacy
基于β_2-肾上腺素能受体激动剂内在功效的临床应用
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUME Hiroaki其他文献

KUME Hiroaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUME Hiroaki', 18)}}的其他基金

Molecularly-targeted therapy for asthma with a focus on migration and contractility of airway smooth muscle cells
哮喘的分子靶向治疗,重点关注气道平滑肌细胞的迁移和收缩性
  • 批准号:
    25461201
  • 财政年份:
    2013
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A molecular pharmacological therapy for asthma based on phenotype changing in the structural cells in airways
基于气道结构细胞表型变化的哮喘分子药理学治疗
  • 批准号:
    22590846
  • 财政年份:
    2010
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A molecular target for preventing airway remodeling
预防气道重塑的分子靶点
  • 批准号:
    19590891
  • 财政年份:
    2007
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Therapy for bronchial asthma by regulating a small G protein as a targeting molecule
通过调节小G蛋白作为靶向分子治疗支气管哮喘
  • 批准号:
    17590785
  • 财政年份:
    2005
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

两种青牛胆属植物中调控PD-1表达的克罗烷二萜的发现及肿瘤免疫调控功能研究
  • 批准号:
    82304336
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
西罗莫司介导Ca2+释放激活PKCα及MLCK/p-MLC通路诱发肺损伤的机制研究
  • 批准号:
    82360016
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
TWIST1介导FGFR2+成纤维细胞向FAP+成纤维细胞转化在克罗恩病肠纤维化发生发展中的作用研究
  • 批准号:
    82370549
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于肠道菌群DL-内肽酶-NOD2通路的克罗恩病肠纤维化发病机制及预警价值研究
  • 批准号:
    82372305
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
ALK3通过谷氨酰胺代谢重编程介导甲状腺未分化癌安罗替尼耐药的机制研究
  • 批准号:
    82304521
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Netrin-1 receptor "deleted in colorectal cancer" (DCC) signalosome in axonal development
Netrin-1 受体“在结直肠癌中缺失”(DCC) 轴突发育中的信号体
  • 批准号:
    488616
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Operating Grants
Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies
用他汀类药物靶向转录共激活剂 YAP 和 TAZ,以防止 HLA 供体特异性抗体导致实体器官移植排斥
  • 批准号:
    10734277
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Actin gating of crosstalk between Rho GTPases in cell migration
细胞迁移中 Rho GTP 酶之间串扰的肌动蛋白门控
  • 批准号:
    10736927
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Bilingualism as a protective factor of ADRD in American Indian adults: the Strong Heart Study
双语是美洲印第安人成人 ADRD 的保护因素:强心脏研究
  • 批准号:
    10582307
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Cholesterol homeostasis in the vertebrate retina
脊椎动物视网膜中的胆固醇稳态
  • 批准号:
    10580969
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了